Memorial Sloan Kettering Cancer Center
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1884-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mskcc.org
A Study of Pembrolizumab and Olaparib in People With Endometrial Cancer or Endometrial Carcinosarcoma
- Conditions
- Endometrial Carcinosarcoma
- Interventions
- First Posted Date
- 2021-12-14
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 26
- Registration Number
- NCT05156268
- Locations
- 🇺🇸
Maria Rubinstein, Rockville Centre, New York, United States
🇺🇸Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States
🇺🇸Memorial Sloan Kettering Cancer Center, New York, New York, United States
A Study of Pembrolizumab With Lenvatinib in Women With Advanced Uterine Carcinosarcoma
- Conditions
- Uterine CarcinosarcomaAdvanced Uterine Carcinosarcoma
- Interventions
- First Posted Date
- 2021-12-07
- Last Posted Date
- 2025-03-13
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 40
- Registration Number
- NCT05147558
- Locations
- 🇺🇸
Memorial Sloan Kettering Bergen (Limited protocol activities), Montvale, New Jersey, United States
🇺🇸Memorial Sloan Kettering Westchester (Limited protocol activities), Harrison, New York, United States
🇺🇸Memorial Sloan Kettering Cancer Center, New York, New York, United States
Imaging Study of 18F-FAC PET Scans to Assess Standard Treatment in People with Pancreatic Cancer
- Conditions
- Pancreatic CancerPancreatic Ductal Adenocarcinoma
- Interventions
- Diagnostic Test: PET Scan
- First Posted Date
- 2021-12-02
- Last Posted Date
- 2024-10-18
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 30
- Registration Number
- NCT05141643
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
A Study of TTI-622 in Combination With Daratumumab Hyaluronidase-fihj in People With Multiple Myeloma
- Conditions
- Multiple Myeloma
- Interventions
- First Posted Date
- 2021-12-01
- Last Posted Date
- 2025-02-17
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 7
- Registration Number
- NCT05139225
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States
🇺🇸Memorial Sloan Kettering Commack, Commack, New York, United States
A Study of Stereotactic Body Radiation Therapy and Radium (Ra-223) Dichloride in Prostate Cancer That Has Spread to the Bones
- Conditions
- Prostate Cancer
- Interventions
- Drug: Radium dichlorideDiagnostic Test: PET Scan
- First Posted Date
- 2021-11-24
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 12
- Registration Number
- NCT05133440
- Locations
- 🇺🇸
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
🇺🇸Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States
🇺🇸University of Colorado (Data Collection Only), Aurora, Colorado, United States
A Study of Multiparametric MRI and pHLIP® ICG in Breast Cancer Imaging During Surgery
- Conditions
- Breast Cancer
- Interventions
- Diagnostic Test: pHLIP® ICG NIRF imaging
- First Posted Date
- 2021-11-23
- Last Posted Date
- 2024-10-15
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 55
- Registration Number
- NCT05130801
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States
🇺🇸Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale, New Jersey, United States
Monitoring for Cancer Spread to the Central Nervous System (CNS) in People With Breast Cancer
- Conditions
- Breast Cancer
- Interventions
- Diagnostic Test: MRIDiagnostic Test: Lumbar puncture
- First Posted Date
- 2021-11-23
- Last Posted Date
- 2025-02-13
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 20
- Registration Number
- NCT05130840
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Study of Plinabulin and Pegfilgrastim in People With Multiple Myeloma Undergoing an Autologous Hematopoietic Stem Cell Transplant (AHCT)
- First Posted Date
- 2021-11-23
- Last Posted Date
- 2024-08-06
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 17
- Registration Number
- NCT05130827
- Locations
- 🇺🇸
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
🇺🇸Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States
Study of 2141-V11 in People With Non-muscle Invasive Bladder Cancer That Did Not Respond to Standard Treatment
- Conditions
- Non-muscle Invasive Bladder Cancer
- Interventions
- Drug: anti-CD40 antibody 2141-V11
- First Posted Date
- 2021-11-19
- Last Posted Date
- 2025-06-04
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 55
- Registration Number
- NCT05126472
- Locations
- 🇺🇸
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States
🇺🇸Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States
🇺🇸Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
A Study of Amivantamab in People With Esophagogastric Cancer
- First Posted Date
- 2021-11-11
- Last Posted Date
- 2024-11-22
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 25
- Registration Number
- NCT05117931
- Locations
- 🇺🇸
University of California, Irvine, Irvine, California, United States
🇺🇸Massachusetts General Hospital (Data Collection Only), Boston, Massachusetts, United States
🇺🇸Memorial Sloan Kettering Basking Ridge (Limited protocol activities), Basking Ridge, New Jersey, United States